| Financial Year |
March 31 2023 |
| Monetary Funds |
226,002,221.14 |
| Held-for-trading Financial Assets |
1,081,130.35 |
| Notes Receivable |
-- |
| Accounts Receivable |
590,932,575.45 |
| Advances to Suppliers |
87,737,784.46 |
| Other Receivables |
27,985,823.76 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
646,031,333.93 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
21,331,835.77 |
| Total Current Assets |
1,686,062,956.44 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
3,721,373.70 |
| Long-term Equity Investment |
-- |
| Investment Properties |
267,130,829.03 |
| Fixed Assetes |
300,684,092.91 |
| Under-construction Projects |
211,867,189.89 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
60,139,602.98 |
| R&D expenses |
-- |
| Goodwill |
519,772,825.05 |
| Long-Term Deferred and Prepaid Expenses |
31,100,879.02 |
| Deferred Income Tax Assets |
32,687,685.72 |
| Other Non-Current Assets |
48,747,204.80 |
| Sub-Total of Non-Current Assets |
1,534,400,490.34 |
| Total Assets |
3,220,463,446.78 |
| Short-Term Loans |
352,076,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
334,314,898.43 |
| Accounts Payable |
150,277,405.02 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
14,514,910.52 |
| Taxes Payable |
45,010,772.57 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
25,767,129.40 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
24,671,139.15 |
| Other Current Liabilities |
12,102,103.41 |
| Sub-Total of Current Liabilities |
1,048,428,504.30 |
| Long-term Loans |
140,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
472,925.05 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
155,657,541.87 |
| Total Liabilities |
1,204,086,046.17 |
| Paid-In Capital(Or Share Stock) |
273,184,096.00 |
| Capital Surplus |
909,283,453.90 |
| Surplus Reserve |
44,823,281.67 |
| LESS:Treasury Stock |
13,400,564.00 |
| Undistributed Profits |
783,676,127.28 |
| Minority Stockholder's Interest |
18,660,707.82 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,997,716,692.79 |
| Owner's Equity（Stockholder's Equity） |
2,016,377,400.61 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,220,463,446.78 |
